Qi Liu
- Aging top 5%
- Molecular Biology top 2%
- CRISPR and Genetic Engineering 23
- Single-cell and spatial transcriptomics 21
- Bioinformatics and Genomic Networks 17
- Advanced biosensing and bioanalysis techniques 12
- RNA and protein synthesis mechanisms 11
- vaccines and immunoinformatics approaches 11
-
- Computational Drug Discovery Methods 22
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 15
- Journals
- Nucleic Acids Research (5 papers)Nature Communications (10 papers)Journal of Clinical Oncology (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Qi Liu
126 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 159
- Business and International Management 98
- Aging 70
- Molecular Biology 2.6k
- Computational Theory and Mathematics 535
- Cancer Research 394
Countries citing papers authored by Qi Liu
This map shows the geographic impact of Qi Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi Liu more than expected).
Fields of papers citing papers by Qi Liu
This network shows the impact of papers produced by Qi Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi Liu. The network helps show where Qi Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Qi Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 7 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 26 | |
| 6 | 2023 | 36 | |
| 7 | 2023 | 3 | |
| 8 | 2022 | 9 | |
| 9 | 2022 | 25 | |
| 10 | 2021 | 37 | |
| 11 | 2021 | 4 | |
| 12 | 2021 | 32 | |
| 13 | 2021 | 46 | |
| 14 | 2020 | 55 | |
| 15 | Novel Albumin Nanoparticle Enhanced the Anti-Insulin-Resistant-Hepatoma Activity of Metformin | 2020 | 1 |
| 16 | 2016 | 94 | |
| 17 | 2015 | 30 | |
| 18 | 2014 | 12 | |
| 19 | 2014 | 9 | |
| 20 | 2012 | 18 |
About Qi Liu
Qi Liu is a scholar working on Computational Theory and Mathematics, Business and International Management and Molecular Biology, having authored 137 papers that have together received 3.6k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (23 papers), Computational Drug Discovery Methods (22 papers), Single-cell and spatial transcriptomics (21 papers), Bioinformatics and Genomic Networks (17 papers), Cancer Genomics and Diagnostics (15 papers), Advanced biosensing and bioanalysis techniques (12 papers), RNA and protein synthesis mechanisms (11 papers) and vaccines and immunoinformatics approaches (11 papers). The work is most often cited by research in Business and International Management (98 citations), Aging (70 citations) and Molecular Biology (2.6k citations). Qi Liu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Guohui Chuai, Chi Zhou, Chenyu Zhu, Ruixin Zhu, Jingchun Sun, Hua Xu, Yubo Zhou, Bin Duan, Dongyu Xue and Qiang Wei. Their work appears in journals such as Nucleic Acids Research, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.